Stephen Stahl

Stephen Stahl, MD, PhD, is an author and professor of psychiatry with expertise in psychopharmacology. He is currently a Professor at the University of California, San Diego and serves as Honorary Fellow in the psychiatry department at the University of Cambridge. He is also the chairman of Neuroscience Education Institute (NEI) and Arbor Scientia Group. Dr. Stahl also currently serves as editor-in-chief of CNS Spectrums. He is also associate editor of Acta Psychiatrica Scandinavica, is former field editor for the International Journal of Neuropsychopharmacology and is on numerous editorial boards of other leading journals including the ACNP’s journal Neuropsychopharmacology. Author of over 500 articles and chapters, and more than 1600 scientific presentations and abstracts, Dr. Stahl is an internationally recognized clinician, researcher and teacher in psychiatry with subspecialty expertise in psychopharmacology. Dr. Stahl has written 33 books and edited ten others, including the best-selling and award winning textbook, Stahl's Essential Psychopharmacology, now in its fourth edition, and the best-selling and award winning clinical manual, Essential Psychopharmacology Prescriber's Guide, now in its fifth edition. Dr. Stahl has served as a Consultant to Arena, Azur, Bionevia, BristolMyers Squibb, Eli Lilly, Endo, Forest, Jazz, J & J, Labopharm, Lundbeck, Marinus, Neuronetics, Novartis, Noven, PamLabs, Pfizer, Pierre Fabre, Sanofi, Sepracor, Servier, Shire, SK Corporation, Solvay, Somaxon, Tetragenex and Vanda; he has served on speakers bureaus for Wyeth and Pfizer and has received grant support from Forest, J & J, Novartis, Organon, PamLabs, Pfizer, Sepracor, Shire, Takeda, Vanda and Wyeth.